Floatz logo

c7r.cd30.car-ebvst cells

Anaplastic Large Cell Lymphoma, ALK-Positive

Baylor College of MedicineCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

15 Active assets in the Anaplastic Large Cell Lymphoma, ALK-Positive cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Mingzhi Zhang
Phase 4BB
Crizotinib
Mingzhi Zhang
Phase 4BB
Inno-206
Huiqiang Huang
Phase 2BB
DEXAMETHASONE
Huiqiang Huang
Phase 2BB
Cyclophosphamide
Huiqiang Huang
Phase 2BB

View all 33 →

Same molecule, other indications

c7r.cd30.car-ebvst cells is also rated in:

diffuse large B-cell lymphomaDormant
CC
Indicative ·
43 / 100
View asset →
anaplastic large cell lymphomaDormant
CC
Indicative ·
43 / 100
View asset →
ALK-negative anaplastic large cell lymphomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →